Key points from article :
SRW Laboratories and Insilico Medicine partner to develop new longevity products using AI.
The goal is to extend healthspan by targeting cellular aging.
AI is being used to screen natural molecules and compounds for their potential to promote healthy aging.
SRW will have access to Insilico's Pharma.AI platform to analyze data and design new therapeutics.
“Aging is a universal issue, and one that we’re closer than ever to solving,” said Alex Zhavoronkov, co-CEO and founder of Insilico.
The partnership is a significant collaboration within the natural supplement category.
The SRW and Insilico partnership is expected to unveil its first AI-assisted product suite in 2024.
